News

Thyroid tumor reclassification eases burden, raises diagnostic questions


 

FROM JAMA ONCOLOGY

References

Dr. Nikiforov is a consultant for Quest Diagnostics. A coauthor, Dr. Sylvia Asa, is a member of the medical advisory board of Leica Aperio, and another coauthor, Dr. Virginia LiVolsi, is a consultant for Veracyte Inc. The project used a facility supported by the National Cancer Institute, and molecular analysis was supported in part by funds from the University of Pittsburgh Cancer Institute and the University of Pittsburgh Medical Center. The Endocrine Pathology Society working group conference was supported by a grant from CBLPath Inc. Dr. Angelos and Dr. Zeiger reported having no disclosures.

sworcester@frontlinemedcom.com

Pages

Recommended Reading

Wide variation in clinical management of thyroid nodules seen in first-ever survey
MDedge Family Medicine
Novel agent for adult GH can be administered once weekly
MDedge Family Medicine
Endocrine Society issues first-ever guidelines for primary adrenal insufficiency
MDedge Family Medicine
Gender identity disorders in males associated with MS
MDedge Family Medicine
Treating maternal subclinical hypothyroidism doesn’t improve childhood IQ
MDedge Family Medicine
Subclinical hyperthyroidism disease tied to higher mortality in elderly
MDedge Family Medicine
VIDEO: Low thyroid function increases odds of type 2 diabetes
MDedge Family Medicine
Morning cortisol rules out adrenal insufficiency
MDedge Family Medicine
Surgery for PHPT improves sleep quality
MDedge Family Medicine
TSH antibody levels predict Graves relapse after thionamides
MDedge Family Medicine